Caris Life Sciences Reports First Quarter 2026 Financial Results Accessibility Statement Skip Navigation Revenue growth of 79% driven by strong performance in molecular profiling services The increase in total revenue was driven primarily by an 85% growth in molecular profiling services revenue, which was $210.8 million for the three months ended March 31, 2026, compared to $114.1 million for the three months ended March 31, 2025. The increase in molecular profiling services revenue was primarily driven by ...